Vifor Pharma
VIFN.SW
$179.34
Share price
0.48%
Change (1 day)
0.59%
Change (1 year)
Categories
Vifor Pharma (VIFN.SW) - P/B ratio
P/B ratio as of April 2024 : 2.68
According to Vifor Pharma's latest financial reports the company has a price-to-book ratio of 2.68.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Vifor Pharma - P/B ratio (from 2009 to 2021)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2021-12-31 | 2.65 | 18.15% |
| 2020-12-31 | 2.24 | -26.88% |
| 2019-12-31 | 3.07 | 48.96% |
| 2018-12-31 | 2.06 | -14.7% |
| 2017-12-31 | 2.42 | -25.44% |
| 2016-12-31 | 3.24 | -37.21% |
| 2015-12-31 | 5.16 | 76.02% |
| 2014-12-31 | 2.93 | -21.66% |
| 2013-12-31 | 3.74 | 49.96% |
| 2012-12-31 | 2.49 | -15.56% |
| 2011-12-31 | 2.95 | -25.33% |
| 2010-12-31 | 3.96 | 24.64% |
| 2009-12-31 | 3.17 |